Drug

Bismuth subsalicylate

Established medicine

ClassCyclooxygenase inhibitorResearchOngoing clinical research

Also known as Basic bismuth salicylate, Bismarex, Bismusal, Bismuth oxide salicylate+13 more

Basic bismuth salicylate, Bismarex, Bismusal, Bismuth oxide salicylate, Estomaquil, Kaopectate, Kaopectate Reformulated Aug 2006, Kola-Pectin DS, Maalox Total Stomach Relief, Maximum Strength Stress, Pepto-Bismol, Percy Medicine, Stress, Stress Liquid, Stress Maximum Strength, Wismutsubsalicylat, Bismuth oxysalicylate.

RxNorm19478 ChEMBLCHEMBL1120UNII62TEY51RR1

Protein targets

Latest activity

beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea and Impact on Acquisition of Gut Antimicrobial Resistance Genes

Clinical trial2026-04-29Terminated · ClinicalTrials.gov

An Exploratory Study of The Effect of Bismuth Subsalicylate on The Gut Microbiome and Host Response in Healthy Adults

Clinical trial2026-03-24Results posted · ClinicalTrials.gov

A Randomized, Double-Blinded, Placebo-controlled, Single-center Phase 1 Pilot Study to Explore the Effect of DAPAglifozin and Stress ( i.v. ACTH) on the Development of DKA After Insulin Withdrawal in Adolescent and Adult Subjects With T1D

Clinical trial2022-08-26Terminated · ClinicalTrials.gov

THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY

Clinical trial2021-02-01Completed · ClinicalTrials.gov

Can Use of Bismuth Subsalicylate in Clostridium Difficile Patients Decrease the Length of Stay and Time to Resolution of Symptoms

Clinical trial2018-07-01Withdrawn · ClinicalTrials.gov

Confocal Endomicroscopy for the Detection of Food Intolerances in Patients With IBS: Add on Control Group: Does Stress Cause Similar Mucosal Changes to Food Antigens?

Clinical trial2016-07-01Withdrawn · ClinicalTrials.gov

Randomized, Double-blind, Placebo-controlled Trial of the Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients in Pakistan

Clinical trial2014-09-01Completed · ClinicalTrials.gov

A Multicenter, Double Blind, Placebo-Controlled Study of Pepto-Bismol® (Bismuth Subsalicylate) on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral TECFIDERA™ (Dimethyl Fumarate) Delayed-Release Capsules Twice Daily

Clinical trial2013-12-01Completed · ClinicalTrials.gov

Levoﬂoxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection

Clinical trial2013-04-01Completed · ClinicalTrials.gov

Herpetic Eye Disease Study (HEDS) II

Clinical trial2010-03-24Completed · ClinicalTrials.gov

CURRENT PRACTICE STUDY OF ANTIBIOTIC TREATMENT OF GASTRIC MALT LYMPHOMA

Clinical trial2001-10-08Completed · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name

Bismuth subsalicylate

Aliases & brands

Basic bismuth salicylateBismarexBismusalBismuth oxide salicylateEstomaquilKaopectateKaopectate Reformulated Aug 2006Kola-Pectin DSMaalox Total Stomach ReliefMaximum Strength StressPepto-BismolPercy MedicineStressStress LiquidStress Maximum StrengthWismutsubsalicylatBismuth oxysalicylate

RxNorm CUI

19478

ChEMBL ID

CHEMBL1120

UNII

62TEY51RR1

Primary mechanism

Cyclooxygenase inhibitor